Organoid bioprocessing company Cellesce has formally launched and published the supporting data package for its first range of colorectal organoids. Based on three and a half years of bioprocess development research, Business News Wales reports that Cellesce has now successfully grown, reliably expanded and characterised a range of ten novel organoids. Ethically derived from colorectal … Continue reading Cellesce launches colorectal tumour organoids

Proton Partners International has announced a new design partnership for all its future UK projects. BQ has reported that the agreement is between the subsidiary of Proton Partners International, Rutherford Estates, and DFJ Designs, a consortium of three architectural design companies, Desco, Fairhurst and JDDK, all of which have worked closely with Proton Partners International … Continue reading Proton Partners signs deal with DFJ Designs

More than thirty Welsh companies will be attending Medica as part of a Welsh Government trade mission next week. Medica attracts over 130,000 specialist visitors from over 120 countries to discover the latest innovations and trends for the medical industry. Of the Welsh companies attending, BQ reports that eighteen will also be exhibiting. Cardiff-based EKF … Continue reading More than 30 Welsh companies attending Medica

ADC Biotechnology, a developer of anti-cancer drugs, has agreed a deal for new premises on the Deeside Industrial Park. The business secured funding in September 2017 to support its expansion plans, with investors including Maven Capital Partners, Seneca and Finance Wales. The Welsh Government also provided a grant. Insider Media reports FI Real Estate Management … Continue reading ADC Biotechnology to move into Deeside site

The Welsh Government has reported that Economy Secretary Ken Skates formally opened Creo Medical’s new facility in Chepstow on October 30th. The company has recently taken on twenty two new members of staff. Creo Medical specialises in the emerging field of surgical endoscopy, which aids minimally invasive surgery by applying microwave and radio wave energy. … Continue reading Creo Medical opens new facility in Chepstow

Chepstow-based drug discovery and development company Apitope has revealed plans to raise funds through an initial public offering (IPO) on the Euronext stock exchange in Brussels. Insider Media reports that the proceeds from the IPO will be used to advance the clinical development the company’s ATX-MS-1467 product for the treatment of MS and ATX-GD-59 for … Continue reading Apitope planning Brussels IPO

Pembroke Dock-based biotechnology and medical device company Mikota has appointed a new chairman. Insider Media has reported that Dr Stewart White, the founding chief executive of Glasgow-based Collagen Solutions plc and most recently its chief strategy officer, has been appointed. Founded in 2014 by Alex Mühlhölzl, David Evans and Dr Christopher Coates, Mikota started trading … Continue reading New chairman for Mikota

WalesOnline has reported that Ambionics is launching a beta trial of its 3D printed prosthetic arms involving twenty children on five continents. Ambionics was founded by Ben Ryan whose son Sol was born in March 2015 with an undetected clot in his arm following a forceps delivery. Surgeons had to amputate just below the elbow … Continue reading 3D printed arms to be trialled worldwide

Frontier Medical Group has launched its new Toto Touch automated lateral turning system at the 2017 European Pressure Ulcer Advisory Panel meeting in Belfast. MediWales reports that Toto Touch is an update on the original Toto system which was designed to support clinicians in the prevention and treatment of pressure ulcers. Developed for acute and … Continue reading Frontier launches new lateral turning system

BBI Solutions has announced the launch of ten infectious disease markers, three inflammatory markers, two fertility markers and an additional cardiac marker. All the antibodies have been tested in either lateral flow or ELISA and are available for sampling. BBI Solutions is in a rapid period of expansion and growth with recent announcements of a … Continue reading More antibodies added to BBI Solutions’ portfolio